Studies have shown that topiramate can be nearly as effective for weight loss as phentermine combined with topiramate over a 1-year period 5.1.5 Effectiveness After GLP1 Therapy While no large-scale clinical trials specifically examine topiramate for post-GLP-1 maintenance , indirect evidence is compelling: Studies have shown topiramate produces 510% weight loss as monotherapy, with less weight regain over time
Another feature of GLP-1 was its action to inhibit glucagon secretion [35], whereas GIP stimulated glucagon secretion [36]
Mechanism of Action GHK-Cu is a tripeptide ( glycyl-histidyl-lysine) bound to copper, naturally found in plasma, saliva, and urine
Further research is needed to fully understand the relationship between semaglutide and NAION risk
The duration of your program will depend on the amount of weight you want to lose as well as how effective the drug and your individual lifestyle changes are
Using both may provide a more comprehensive shield for your liver's daily functions